Global /Taiwan /Healthcare /Medical Devices /6918
chevron_leftBack
A Plus Biotechnology Co., Ltd. logo

A Plus Biotechnology Co., Ltd.

6918
TWSE: 6918 Delayed
74.30TWD -0.7%
2.35 USD
As of 15 June 2026, A Plus Biotechnology Co., Ltd. has a market cap of $79.27M USD, ranking #27203 globally and #1546 in Taiwan. It ranks #2443 in the Healthcare sector, and #499 in the Medical Devices industry.
Global Rank
27203
Country Rank
1546
Sector Rank
2443
Industry Rank
499
Key Stats
Market Cap
$79.27MUSD
2.5B TWD
Enterprise Value
$63.06MUSD
1.99B TWD
Revenue (TTM)
$26.47MUSD
835.89M TWD
EBITDA (TTM)
$7.11MUSD
224.9M TWD
Net Income (TTM)
$5.36MUSD
169.38M TWD
EBITDA Margin
27%
Profit Margin
20%
PE Ratio
14.4
PS Ratio
3.0
PB Ratio
2.0
EV/EBITDA
8.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Xiang-Wei Luo open_in_new
Founded
2009
Website
aplusbio.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.7% 0.5% -7.6% -8.2% -12% -31%

News

Loading...

Markets

Exchange Ticker Price
Taiwan Stock Exchange
MIC: XTAI
PRIMARY
6918
愛派司生技股份有限公司
ISIN: TW0006918006
Shares Out.:
34.071M1
TV:
SA:
YF:
GF:
BA:
MS:
74.30 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About A Plus Biotechnology Co., Ltd.

A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of orthopedic and other medical devices. The company offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, biologics. It also provides bone grafts. A Plus Biotechnology Co., Ltd. was founded in 2009 and is based in New Taipei City, Taiwan.

Similar Companies

Industry: Medical Devices (Taiwan)
Name
Market Cap diff.
PE
$668.26M
21.1B TWD
743%
29.1
$377.5M
11.92B TWD
376%
8.3
YDES
$364.92M
360%
-
$302.31M
9.55B TWD
281%
17.5
4107
$254.54M
8.04B TWD
221%
15.0
1788
$191.02M
6.03B TWD
141%
16.4
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
218K%
25.8
$160.73B
203K%
56.7
$159.07B
201K%
25.6
DHR
$126.55B
160K%
34.7
SYK
$120.69B
152K%
38.3
MDT
$101.9B
128K%
22.2
chevron_leftBack